Ex-Post Assessment of Merger Effects : The Case of Pfizer and Pharmacia, 2003
Year of publication: |
2014
|
---|---|
Authors: | Leheyda, Nina |
Other Persons: | Beschorner, Patrick (contributor) ; Hüschelrath, Kai (contributor) |
Publisher: |
[2014]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Fusion | Merger | Wirkungsanalyse | Impact assessment | Fusionskontrolle | Merger control | Wettbewerb | Competition | Theorie | Theory |
Extent: | 1 Online-Ressource (39 p) |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments 2011 erstellt |
Other identifiers: | 10.2139/ssrn.1852389 [DOI] |
Classification: | K21 - Antitrust Law ; L42 - Vertical Restraints; Resale Price Maintenance; Quantity Discounts ; L62 - Automobiles; Other Transportation Equipment |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Ex-post assessment of merger effects : the case of Pfizer and Pharmacia (2003)
Leheyda, Nina, (2011)
-
Innovation Competition, Unilateral Effects and Merger Policy
Petit, Nicolas, (2020)
-
Endogenous choice of minority shareholdings : effects on product market competition
Haas, Samuel de, (2019)
- More ...
-
Ex-post assessment of merger effects: the case of Pfizer and Pharmacia (2003)
Leheyda, Nina, (2011)
-
The effects of the block exemption regulation reform on the Swiss car market
Leheyda, Nina, (2011)
-
Buchbesprechungen / Book Reviews
Schmidt, André, (2008)
- More ...